The first-in-class blood-based pan-cancer early detection test
With the mission to detect cancer when it is still curable, SeekInCare® has been developed as a pan cancer detection test that takes a panoramic view of blood cell-free cancer signatures and a multi-omics approach incorporating genomic and epigenetic alterations in conjunction with clinically validated protein biomarkers. Equipped with proprietary AI- and big data-driven CRS algorithm, SeekInCare® exhibits superior effectiveness to detect dozens of cancer types at high specificity. SeekInCare® is intended to use for the individuals with elevated risks of cancer such as smoking, chronic hepatitis, aging, etc., in conjunction with the approved conventional single cancer type screening tests.
panoramic view of cell-free cancer signatures in blood
multi-omics approach that incorporated genomic and epigenetic alterations in conjunction with protein biomarkers
Big data + AI
◉ Sample requirement: 10ml peripheral blood
◉ Result readout: Cancer Risk Score (CRS) + Tissue Of Origin